title: Long lasting efficacy of Bezalip retard on the regulation of lipid levels after discontinuation of administration in patients with hyperlipoproteinemia.
authors.affiliation: 3rd Department Semmelweis Medical University, Budapest.
authors.forename: A
authors.initials: A
authors.lastname: Császár
authors.forename: I
authors.initials: I
authors.lastname: Karádi
authors.forename: G
authors.initials: G
authors.lastname: Köszegi
authors.forename: G
authors.initials: G
authors.lastname: Pados
authors.forename: M
authors.initials: M
authors.lastname: Németh-Csóka
authors.forename: M
authors.initials: M
authors.lastname: Pichler
authors.forename: L
authors.initials: L
authors.lastname: Romics
mesh_terms: D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001629:Bezafibrate / Q000008:administration & dosage*; D001786:Blood Glucose / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy* / Q000201:enzymology; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
chemical_list: D001786:Blood Glucose; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D003692:Delayed-Action Preparations; D008055:Lipids; D014280:Triglycerides; D002784:Cholesterol; D000469:Alkaline Phosphatase; D001629:Bezafibrate